Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146482 · ClinicalTrials.gov registry record · NA
Access to a Sit-stand Computer Workstation and Back Pain
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02146482: Completed NA study, sponsored by Stanford University.
NCT02146482 is a NA study that has completed, run by Stanford University. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02146482, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the changes in back pain from access to a sit-stand workstation. Other muscle and joint pain and/or discomfort will also be evaluated. We hypothesize that access to a sit-stand workstation will allow one to experience postural variation and reduce back pain.
Primary Outcome
The Roland-Morris Disability Questionnaire is designed to assess self-rated physical disability caused by low back pain. The patient is asked to agree or disagree with 24 different statements related to their back pain. The end score is the sum of the agreed statements. The score ranges from 0 (no disability) to 24 (maximum disability).
Interventions
- OTHER Sit-stand computer workstation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT02146482 record still lists
NCT02146482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Sit-stand computer workstation is the first listed.
NCT02146482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02146482 about?
NCT02146482 is a clinical study titled "Access to a Sit-stand Computer Workstation and Back Pain". The purpose of the study is to evaluate the changes in back pain from access to a sit-stand workstation. Other muscle and joint pain and/or discomfort will also be evaluated. We hypothesize that access to a sit-stand workstation will allow one to experience postural variation and reduce back pain.
What is the current status of trial NCT02146482?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2013-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02146482?
The interventions under investigation include: Sit-stand computer workstation (OTHER).
Who is sponsoring clinical trial NCT02146482?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02146482's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia